Hims & Hers expanded its platform functionality. Healthcare providers can now prescribe Eli Lilly’s weight-loss drug Zepbound in vials and KwikPen formats to the LillyDirect pharmacy service.
Providers may also prescribe the diabetes treatment Foundayo to LillyDirect. This collaboration leverages direct-to-consumer channels to broaden access to GLP-1 medications.
Hims & Hers patients can now utilize self-pay pricing options through LillyDirect.
Hims & Hers shares rose on the news. Eli Lilly stock showed no significant market reaction.